<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00204269</url>
  </required_header>
  <id_info>
    <org_study_id>IRM 2002/37</org_study_id>
    <secondary_id>TGT-04/2002</secondary_id>
    <nct_id>NCT00204269</nct_id>
  </id_info>
  <brief_title>Three-Year Trial on a New Testosterone Gel</brief_title>
  <official_title>Three-Year Trial on a New Testosterone Gel: Clinical Efficacy, Tolerability and Compliance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Muenster</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Dr. August Wolff GmbH &amp; Co. KG Arzneimittel</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Muenster</source>
  <brief_summary>
    <textblock>
      The objective of the study is to examine the efficacy and tolerability of a
      three-year-Testosterone replacement therapy in hypogonadal patients as well as the patient's
      compliance. The replacement therapy will be performed with a new Testosterone Gel examined in
      previous trials as Testosteron Gel Wolff.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of the study is to examine the efficacy and tolerability of a
      three-year-Testosterone replacement therapy in hypogonadal patients as well as the patient's
      compliance. The replacement therapy will be performed with a new Testosterone Gel examined in
      previous trials as Testosteron Gel Wolff (TGW).

      A minimum of 100 patients will be recruited and evenly distributed to two treatment arms. 1st
      arm: dermal (non-scrotal) application of TGW. 2nd arm: scrotal application of TGW.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>January 2003</start_date>
  <completion_date>September 2006</completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>testosterone levels</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>hormones</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>sexual function and mood disorder (questionnaire)</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>compliance (drug accountability)</measure>
  </secondary_outcome>
  <enrollment>100</enrollment>
  <condition>Hypogonadism</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Testosterone Gel Wolff</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        men with

          -  hypergonadotropic hypogonadism

          -  hypogonadotropic hypogonadism

          -  late-onset hypogonadism

        combined with an initial Testosterone serum level of &lt; 11 nmol/l

        Exclusion Criteria:

          -  known or suspected carcinoma of the prostate

          -  clinically relevant abnormalities in clinical chemistry or haematology

          -  any severe medical conditions at the opinion of the investigator
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eberhard Nieschlag, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute of Reproductive Medicine of the University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Clinic Charité, Division of Urology</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Franziskus-Hospital, Division of Urology</name>
      <address>
        <city>Bielefeld</city>
        <zip>33615</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Clinic Bonn, Division of Dermatology</name>
      <address>
        <city>Bonn</city>
        <zip>53105</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical University Clinic II, Division of Internal Medicine/Andrology</name>
      <address>
        <city>Cologne</city>
        <zip>50924</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Clinic Essen, Division of Internal Medicine</name>
      <address>
        <city>Essen</city>
        <zip>45147</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>J.-W. Goethe University, Medical Clinic I, Division of Internal Medicine</name>
      <address>
        <city>Frankfurt</city>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Clinic Giessen, Division of Dermatology/Andrology</name>
      <address>
        <city>Giessen</city>
        <zip>35385</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Clinic Halle Wittenberg, Division of Urology/Andrology</name>
      <address>
        <city>Halle (Saale)</city>
        <zip>06120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Endokrinologikum Hamburg</name>
      <address>
        <city>Hamburg</city>
        <zip>22767</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Medical Clinic Hannover</name>
      <address>
        <city>Hannover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Clinic Leipzig, Division of Dermatology/Andrology</name>
      <address>
        <city>Leipzig</city>
        <zip>04103</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Otto-von-Guerike-University, Clinic of Endocrinology</name>
      <address>
        <city>Magdeburg</city>
        <zip>39120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Phillips-University-Clinic Marburg, Division of Dermatology/Andrology</name>
      <address>
        <city>Marburg</city>
        <zip>35037</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Insitute of Reproductive Medicine of the University</name>
      <address>
        <city>Muenster</city>
        <zip>48129</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Private Practice of Urology</name>
      <address>
        <city>Nuernberg</city>
        <zip>90441</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Kühnert B, Byrne M, Simoni M, Köpcke W, Gerss J, Lemmnitz G, Nieschlag E. Testosterone substitution with a new transdermal, hydroalcoholic gel applied to scrotal or non-scrotal skin: a multicentre trial. Eur J Endocrinol. 2005 Aug;153(2):317-26.</citation>
    <PMID>16061839</PMID>
  </reference>
  <verification_date>May 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 12, 2005</study_first_submitted>
  <study_first_submitted_qc>September 12, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2005</study_first_posted>
  <last_update_submitted>May 12, 2006</last_update_submitted>
  <last_update_submitted_qc>May 12, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 15, 2006</last_update_posted>
  <keyword>Hypogonadism</keyword>
  <keyword>Testosterone</keyword>
  <keyword>Substitution</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypogonadism</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Testosterone</mesh_term>
    <mesh_term>Testosterone enanthate</mesh_term>
    <mesh_term>Testosterone undecanoate</mesh_term>
    <mesh_term>Testosterone 17 beta-cypionate</mesh_term>
    <mesh_term>Methyltestosterone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

